Webinar on

HIV Science & HIV Research

September 30, 2021

HIV Science-2021

Theme: Advance Research in order to find an Effective Vaccine

We are delighted to invite all the participants globally to attend the “Webinar on HIV Science & HIV Research” which is schedule on September 30, 2021. The primary topic of the webinar is “Advance Research in order to find an effective vaccine”.

Webinar on HIV Science & HIV Research, with members from around the world focused on learning about HIV Science & HIV Research, this is your single best opportunity to reach the largest assemblage of participants from the hospitals, Universities, community. HIV webinar will conduct demonstrations, distribute information, meet with current and potential researchers and receive name recognition event.

Session1: HIV Sciences & HIV Research

HIV stands for Human Immunodeficiency Virus, a pathogen that works by attacking the human immune system. It belongs to a class of viruses called retroviruses and more specifically, a subgroup called lentiviruses, or viruses that cause disease slowly. HIV/AIDS research includes all medical research that attempts to prevent, treat, or cure HIV/AIDS, as well as fundamental research about the nature of HIV as an infectious agent and AIDS as the disease caused by HIV.

Session2: HIV Life cycle & HIV Symptoms

The HIV Life cycle includes the complete steps from the starting entry of the virus in to a person's body till the infected person’s death. Once after the entry of virus into the body it completes whole replication process to multiple itself in the host body. So that HIV becomes strong and destroys immune system. There are several stages in HIV life cycle that can take years to show the impact on host body. Using medications can suppress the HIV but there is no cure for it. HIV life cycle helps the scientists to study when the virus will be weak in the host body to reduce its multiplication in the host body.

The symptoms of recent HIV infection is difficult to identify apart from the symptoms of viral infections. Many people with recent HIV infection doesn't notice symptoms. In few people HIV may slowly damage immune system without any symptoms. However, these are the symptoms of HIV infection. Fever, Fatigue, Achy muscles, joint pain, swollen lymph nodes, sore throat, headache, skin rashes, nausea, vomiting, diarrhea, weight loss, dry cough, pneumonia, night sweats, nail changes, yeast infections, confusion or difficulty concentrating, cold sores, genital herpes, tingling weakness, menstrual irregularities.

Session 3: Advances in HIV Tests

Many advanced HIV testing methodologies has been developed to reduce the risk of HIV infection. HIV testing helps to improve the health outcomes for the people living with HIV. Window period, ELISA, ELISA dongle, Western blot, Rapid or point-of-care tests, Interpreting antibody tests, Accuracy of HIV testing are the Antibody tests. Some other methods for HIV testing are Antigen tests, Nucleic acid-based tests, Screening, CD4 T-cell count, Oral tests, AIDS denialism and fraudulent testing.

Session4: HIV Nursing

HIV patients suffer psychologically apart from physically as they are subjected to social isolation. Nurses play a very important role in treating and helping HIV patient and also help in prevention of the spread of this very harmful virus. Nurses also give mental support to HIV patient apart from helping him to withstand with the dangerous virus.

Session 5: Advanced HIV Infection Preventive Measures

Medications can control the growth of HIV infection but, it is not completely curable. Prevention of HIV is better than cure. The different kinds of preventive measure are using a new condom every time having sex, knowing yours and your partners HIV status, limiting the number of sexual partners, using new needles for the injectable drug use, taking medical care immediately after suspected HIV exposure.

Session6: Innovative HIV Drugs & Drug Resistance

Currently many biopharmaceutical companies conducting researches on invention of drug to cure HIV. Most of the innovated drugs are in clinical trials and are awaiting for FDA approval. At present there are few classes of drugs which can suppress the virus they are: Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs), Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Fusion Inhibitors, CCR5 Antagonist, integrate Inhibitors, Fixed-Dose Combinations. The above classified drugs can control the growth of virus but due to drug resistance of HIV it is not completely curable.

 

Importance and Scope:

Theme of the Webinar “Advance Research in Order to Find Effective Vaccine” conveys the essential notion that we tend to showcase to the planet. HIV 2021 prioritizes the high quality researches and technologies used for human health, welfare and convenience. Folks from each genre i.e. the extremely classified professionals, scientists,  researchers and young innovators have an excellent deal during this as they will be having an opportunity for diversification and world communication. We tend to believe HIV 2020 can start up as a seminar study and a platform jam-packed with public awareness.

Business worth of HIV:

In June 1981, scientists reported the first clinical evidence of a disease known as acquired immunodeficiency syndrome, or AIDS. Its cause, the human immunodeficiency virus (HIV), was acknowledged in 1983. Since the start of the epidemic in 1981, around 75 million have become infected with HIV and around 32 million people have died of AIDS-related illnesses. In 2018, there were 37.9 million people living with HIV. New HIV infections have fallen by 16% since 2010 (by 41% among children) and AIDS-related deaths have fallen by 55% since the peak in 2004. The United Nation family has been in the forefront of this improvement. Ending AIDS by 2030 is an integral part of the Sustainable Development Goals (SDGs), which were unanimously adopted by United Nations Member States in 2015. HIV Treatment Access: in 2018, 23.3 million folks with HIV (62%) were accessing antiretroviral medical care (ART) globally, a rise of one.6 million since 2017 and up from eight million in 2010. Mother-to-Child Transmission: In 2018, ninety two of pregnant ladies with HIV received ART to stop transmission HIV to their babies throughout physiological state and childbearing and to shield their own health. This is often compared to forty ninth in 2010. AIDS-related Deaths: AIDS-related deaths are reduced by over fifty fifth since the height in 2004. In 2018, around 770,000 folk sided from AIDS-related diseases worldwide, compared to one.2 million in a pair of010 and one.7 million in 2004. Regional Impact: the overwhelming majority of individuals with HIV are in low- and middle-income countries. In 2018, there have been twenty.6 million folks with HIV (57%) in Japanese and southern continent, 5.0 million (13%) in western and Central African Republic, 5.9 million (16%) in Asia and therefore the Pacific, and 2.2 million (6%) in Western and Central Europe and North America

Funding for HIV:To finish AIDS as a public health threat by 2030, UNAIDS estimates that US$26.2 billion are going to be needed for the world HIV response in two020 alone. This implies the planet should increase the number of resources out there for HIV by US$1.5 billion every year between 2016 and 2020, a scenario that's wanting more and more unlikely.

• In recent years, high-income countries have reduced funding for the HIV response in low- and middle-income countries, with a seven-membered decrease according between 2015 and 2016. Philanthropic donations, on the opposite hand, have up for the past 3 consecutive years.
Universities related to HIV/AIDS Worldwide:
USA:
Augusta University
Wayne State University
Penn University
University of Maryland
Drexel University
University Of Miami
University of Georgia
Harvard University
Washington University
University of Illinois
University of Minnesota
University of Charleston
West Virginia University
Europe:
University of Cambridge
University of Oxford
University of Copenhagen
University College London
Swiss Federal Institute of Technology Zurich
Imperial College London
University of Zurich
Karolinska Institute
University of Manchester
University of Munich
University of Edinburgh
Pierre and Marie Curie University
Catholic University of Leuven
Heidelberg University
University of Helsinki
Asia Pacific:
Osaka University
University of Tokyo
National University of Singapore
Kyoto University
Mahidol University
Tel Aviv University
University of Hong Kong
Keio University
Hebrew University of Jerusalem
Seoul National University
National Taiwan University
Sun Yat-sen University
Fudan University
Zhejiang University
Peking University
Middle East:
Alexandria University
Cairo University
American University of Kuwait
The Lebanese American University (LAU)
Weill Cornell Medical College in Qatar
Paris-Sorbonne University Abu Dhabi
Mohammed bin Rashid University of Medicine and Health Sciences
Hebrew University
King Saud bin Abdulaziz University for Health Sciences
King Saud University
Gulf Medical University
Sana'a University
HIV Related Association & Societies:
USA:
American Academy of HIV Medicine
American Sexual Health Association
Association of Nurses in AIDS Care
Association for Professionals in Infection Control and Epidemiology
International AIDS Society – USA
International AIDS Society
Infectious Diseases Society of America
British HIV Association
Australasian Society for HIV Medicine
HIV Medicine Association
International Association of Physicians in AIDS Care
National Medical Association
HIV Medicine Association
Europe:
The European AIDS Clinical Society
Aids Hilfe Wien Austria
EATG (European AIDS Treatment Group) Belgium
Czech AIDS Help Society Czech Republic
AIDS Fondnet Denmark
Deutche AIDS-Hilfe / AIDS Action Europe Germany
Global Network of People Living with HIV Netherlands
ARAS - Romanian Association against AIDS Romania
Alliance Global Ukraine
European AIDS Treatment Group
HIV Pharmacy Association
Asia Pacific:
CARAM Asia
National AIDS Programme
National Center for HIV/AIDS, Dermatology and STDs
AIDS Concern
Hong Kong AIDS Foundation
The Society for AIDS Care
HIV Medicine Association of India
AIDS Clinical Center
Korean HIV/AIDS Prevention and Support Center
Taiwan Tongzhi Hotline Association
Middle East:
Egyptian AIDS Society
Egyptian Network of NGOs fighting AIDS
AIDS Research Center of Iran
HATAM - HIV/AIDS Treatment and Research Center
Pozitif Yasam Dernegi (Positive Living Association)
Saudi Charity Association for AIDS Patients
National AIDS Programme
Israel AIDS task force
National HIV/AIDS program
Funding bodies:
Centres for Disease Control (CDC)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Child Health and Human Development (NICHD)
NIH Office of AIDS Research (OAR)
Irish Aid
Elton john AIDS foundation
Mac AIDS fund
The global fund
The Road Ahead:
HIV market can see modest growth to $22.5 billion by 2025. The human immunological disorder virus (HIV) market across the 9 major countries of the USA, France, Germany, Italy, Spain, the UK, Japan, Brazil, and China, is about to grow from $16.3 billion in 2015 to $22.5 billion by 2025, representing a compound annual rate of simply over three-dimensional, in step with Global Data, a recognized leader in providing business info and analytics.
Conclusion:
HIV/AIDS 2021 through this learning experience dreams for a society where HIV infections are rare and when they do follow, all person, irrespective of age, gender, race/ethnicity, sexual orientation, gender identity or socio-economic circumstance, will have unrestricted access to high quality, life-extending care, free from disgrace and discrimination.
References:
https://www.who.int/gho/hiv/en/
https://www.avert.org/professionals/hiv-around-world/global-response/funding.

 

  • HIV Sciences & HIV Research
  • HIV Life cycle & HIV Symptoms
  • Advances in HIV Tests
  • HIV Nursing
  • Advanced HIV Infection preventive measures
  • Innovative HIV Drugs & Drug Resistance